Procter & Gamble's much-publicized Intrinsa sex patch was rejected by the Food & Drug Administration five years ago for several reasons.
The fact that a sexual device was not approved by the American government should come as no surprise, but perhaps the Brits should have taken note of the FDA's reasoning.
Intrinsa, a testosterone patch for postmenopausal women, is designed to combat sexual dysfunction and has been available in Europe for several years, according to Reuters. But until now, there was little sign of danger. Minor side effects had been reported and the most serious concern we'd heard is that Instrinsa was failing to provide any sort of positive effect-- sort of like your average Viagra knockoff available for $12 per 100mg's on the internet.
Recently, The Drug and Therapeutics Bulletin reported on these recent studies and found that "the long term safety of the treatment is unknown. Unwanted side effects are common and not always reversible. For all these reasons, we cannot recommend Intrinsa for use in women with sexual dysfunction."
Guess we're back to the drawing board on solving female sexual dysfunction... although the jury's still out on whether Cialis or Viagra are living up to their hype at the other end of the spectrum...
Photo via this link.
Related:
Leave a Comment